Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
IAC Express
|
2012 Issues
|
Issue 994
IAC Express: Weekly immunization news and information
Issue 994: May 15, 2012

TOP STORIES

IAC HANDOUTS

VACCINE INFORMATION STATEMENTS

JOURNAL ARTICLES AND NEWSLETTERS

CONFERENCES AND MEETINGS



TOP STORIES

New: May 2012 issue of Needle Tips is now online
The May 2012 issue of Needle Tips is now online. This issue presents an array of materials that healthcare professionals can rely on to vaccinate people of all ages. Readers will find the two recently published 2012 U.S. immunization schedules, one for children/teens and one for adults; a tribute to retiring CDC immunization expert William Atkinson, MD, MPH; a new handout for patients to help them find old immunization records, and much more.

The issue also includes the "Ask the Experts" column from CDC medical epidemiologist Andrew T. Kroger, MD, MPH; nurse educator Donna L. Weaver, RN, MN; medical officer Iyabode Akinsanya-Beysolow, MD, MPH; and medical epidemiologist William L. Atkinson, MD, MPH.

Back to top


CDC publishes guidance for vaccinating children during the 2012 Pentacel and Daptacel shortage
On May 11, CDC published Guidance for Vaccinating Children during the 2012 Pentacel and Daptacel Shortage. The four-page document comprises a page of general information, two pages of sample schedules for completing the series using various single-antigen and combination vaccines, and a page of links to reference materials. The page of general information is reprinted below.

Guidance for Vaccinating Children during the 2012 Pentacel and Daptacel Shortage

Sanofi Pasteur’s Pentacel (DTaP-IPV/Hib) and Daptacel (DTaP) are expected to be in short supply throughout the summer of 2012. Practices using these vaccines may need to find alternatives during the shortage.

Providers should continue to follow the recommended immunization schedule and ensure that patients receive all recommended doses of DTaP, Hib, and polio vaccines.

Vaccines for Children (VFC) providers should contact their state or local immunization program for guidance about ordering vaccines.

Options include [the following]

  • Using DTaP, IPV, and Hib vaccines to complete a series begun with Pentacel. There is a sufficient supply of these products to meet the anticipated demand.
     
  • Other combination vaccines containing DTaP and Hib vaccines may also be used to complete the series.
Considerations when changing vaccine products
  • The Advisory Committee on Immunization Practices (ACIP) recommends using the same brand of vaccine for all doses of a vaccination series, when feasible. If providers do not know or do not have available the brand of vaccine previously administered, another brand may be used.
     
  • With the exception of Hiberix, which is licensed only for use as the last dose (booster) in the Hib series, Hib vaccines are interchangeable. If different brands of a vaccine require different numbers of doses, use the higher number when mixing brands. The Hib vaccine component in Pentacel is licensed as a four-dose series.
Additional vaccine information and sample schedules using single component and combination vaccines for children who have already received one, two, or three doses of Pentacel are available.

Back to top


CDC's "Epidemiology and Prevention of Vaccine-Preventable Diseases 2012" course now in web-on-demand format
The "Epidemiology and Prevention of Vaccine-Preventable Diseases 2012" course is now available as an 11-module web-on-demand series. Updated annually to provide the latest recommendations from ACIP, the course presents the most current information in the constantly changing field of immunization. Each of the 11 modules has a run time of 70 to 90 minutes and includes case studies and a discussion of frequently asked questions. Continuing education credit is available.

Back to top


IAC HANDOUTS

IAC updates standing orders for administering HPV and Tdap/Td vaccines to adults
IAC recently updated Standing Orders for Administering Human Papillomavirus Vaccine to Adults and Standing Orders for Administering Tdap/Td to Adults (formerly titled Standing Orders for Administering Td/Tdap to Adults). The revisions reflect changes CDC recently made to its vaccine recommendations.

Related Link
Back to top


VACCINE INFORMATION STATEMENTS

IAC posts newly updated VIS for MMR vaccine in seven languages
IAC recently posted the VIS for MMR vaccine in these seven languages: Spanish, Arabic, Chinese, French, Russian, Somali, and Vietnamese.
Back to top


CDC makes minor wording change in its recently published VIS for MMR vaccine
On May 3, CDC sent the following notice about its recently published VIS for MMR vaccine, which was released on April 20.

A minor change has been made in the recently published MMR VIS. The sentence in Section 2 that originally read, "Some infants younger than 12 months should get a dose of MMR if they are traveling overseas" has been changed to the more correct, "Some infants younger than 12 months should get a dose of MMR if they are traveling out of the country."

The updated version has been posted on CDC's VIS webpage. The edition date (4/20/12) has NOT changed. Providers who have already printed the unmodified version may still use it. Others, please download and use the updated version.


IAC Express editor's note: The VIS for MMR vaccine that IAC posted has been updated with the change noted above, as have all the translations.

Back to top


JOURNAL ARTICLES AND NEWSLETTERS

CDC publishes information about ACIP's new framework for developing immunization recommendations
CDC published New Framework (GRADE) for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices in the May 11 issue of MMWR (page 327). A press summary of the article is reprinted below.

The CDC’s Advisory Committee on Immunization Practices (ACIP) has adopted a new framework for developing evidence-based recommendations for the use of vaccines that is based on the GRADE approach. GRADE stands for Grading of Recommendations Assessment, Development and Evaluation. GRADE is used by more than 60 major organizations, including the American Academy of Family Physicians, American College of Physicians, Infectious Diseases Society of America, and the World Health Organization. Using the GRADE framework, ACIP will systematically assess the type or quality of evidence about a vaccine’s expected health impacts and the balance of health benefits and risks, along with the values and preferences of persons affected, and health economic analyses. Use of this new framework is expected to enhance transparency, consistency, and communication.

Back to top


CONFERENCES AND MEETINGS

Reminder: National Conference on Immunization and Health Coalitions planned for May 23–25 in New Orleans
The 10th National Conference on Immunization and Health Coalitions (NCIHC) will take place in New Orleans on May 23–25. NCIHC is the only conference solely dedicated to collaboration and partnership as a way to improve the health status of communities. It offers skills-building, tools, and practical examples to help local, state, and national organizations build and sustain successful partnerships.

Among the speakers at this year's conference is Seth Mnookin, author of the acclaimed book The Panic Virus, A True Story of Medicine, Science, and Fear.

Related Links Back to top



About IAC Express 
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.
If you have trouble receiving or displaying IAC Express messages, visit our online help section.
IAC Express is supported in part by Grant No. U38IP000589 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: Baxter Healthcare Corp.; CSL Biotherapies; GlaxoSmithKline; MedImmune, Inc.; Merck Sharp & Dohme Corp.; Novartis Vaccines; Ortho Clinical Diagnostics, Inc.; Pfizer, Inc.; and sanofi pasteur.
IAC Express Disclaimer
ISSN: 1526-1786

Our mailing address is
Immunization Action Coalition
1573 Selby Ave, Ste 234
St. Paul, MN 55104


Copyright (C) 2012 Immunization Action Coalition
All rights reserved.
Subscribe Today: IAC Express, Needle Tips, and Vaccinate Adults: the up-to-date immunization information you need
IAC Express
IAC Express Home
2014 Issues
2013 Issues
2012 Issues
2011 Issues
2010 - 1997 Issues
Praise for IAC Express
Help
Disclaimer
Video of the Week
Herpes Zoster Video: Who's at risk and who should be vaccinated
Herpes Zoster - Who's at risk and who should be vaccinated: Dr. Craig Hales discusses who should, and who should not, receive the zoster vaccine in this video from CDC and Medscape.
Log-in required
Visit the VOTW archive
Issue Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
Publication Staff
Editor: Deborah L. Wexler, MD
Managing Editor: Dale Thompson, MA
Associate Editor: Teresa Anderson, DDS, MPH
Editorial Assistant: Janelle Tangonan Anderson
Additional Information
News & Information
Media coverage about vaccines and vaccine-preventable diseases
Calendar of Events
Conferences and meetings on immunization
Shop IAC
Record cards, laminated schedules and more
 
This page was reviewed on January 27, 2014
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.